Literature DB >> 17126424

Characterization of a 60S complex of the adenomatous polyposis coli tumor suppressor protein.

Sreekala Mahadevaiyer1, Chong Xu, Barry M Gumbiner.   

Abstract

The tumor suppressor protein adenomatous polyposis coli (APC) is a multifunctional protein with a well characterized role in the Wnt signal transduction pathway and roles in cytoskeletal regulation and cell polarity. The soluble pool of APC protein in colon epithelial tumor cells exists in two distinct complexes fractionating at approximately 20S and approximately 60S in size. The 20S complex contains components of the beta-catenin destruction complex and probably functions in the Wnt pathway. In this study, we characterized the molecular nature of the 60S APC- containing complex by examining known potential binding partners of APC. 60S APC did not contain EB1 or diaphanous, proteins that have been reported to interact with APC and are implicated in microtubule plus end stabilization. Nor did the two other microtubule associated proteins, MAP4 or KAP3, which is thought to link APC to kinesin motor proteins, associate with the 60S complex. Minor fractions of alpha-tubulin, gamma-tubulin and IQGAP1, a Rac1 and CDC42 effector that interacts with APC, specifically associated with APC in the 60S fraction. We propose that 60S APC is a discrete high molecular weight complex with a novel function in cytoskeletal regulation in epithelial cells apart from its well established role in targeting catenin destruction or its proposed role in microtubule plus end stabilization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126424      PMCID: PMC1808328          DOI: 10.1016/j.bbamcr.2006.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  44 in total

Review 1.  Microtubule nucleation.

Authors:  Didier Job; Odile Valiron; Berl Oakley
Journal:  Curr Opin Cell Biol       Date:  2003-02       Impact factor: 8.382

2.  The multiple functions of tumour suppressors: it's all in APC.

Authors:  Riccardo Fodde
Journal:  Nat Cell Biol       Date:  2003-03       Impact factor: 28.824

3.  Tables for estimating sedimentation through linear concentration gradients of sucrose solution.

Authors:  C R McEwen
Journal:  Anal Biochem       Date:  1967-07       Impact factor: 3.365

4.  Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2003-01-29       Impact factor: 49.962

5.  Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration.

Authors:  Takashi Watanabe; Shujie Wang; Jun Noritake; Kazumasa Sato; Masaki Fukata; Mikito Takefuji; Masato Nakagawa; Nanae Izumi; Tetsu Akiyama; Kozo Kaibuchi
Journal:  Dev Cell       Date:  2004-12       Impact factor: 12.270

6.  Adenomatous polyposis coli and EB1 localize in close proximity of the mother centriole and EB1 is a functional component of centrosomes.

Authors:  Ryan K Louie; Shirin Bahmanyar; Kathleen A Siemers; Violet Votin; Paul Chang; Tim Stearns; W James Nelson; Angela I M Barth
Journal:  J Cell Sci       Date:  2004-02-17       Impact factor: 5.285

7.  EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration.

Authors:  Ying Wen; Christina H Eng; Jan Schmoranzer; Noemi Cabrera-Poch; Edward J S Morris; Michael Chen; Bradley J Wallar; Arthur S Alberts; Gregg G Gundersen
Journal:  Nat Cell Biol       Date:  2004-08-15       Impact factor: 28.824

Review 8.  The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium.

Authors:  Inke S Näthke
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

Review 9.  Adenomatous polyposis coli proteins and cell adhesion.

Authors:  Mariann Bienz; Fumihiko Hamada
Journal:  Curr Opin Cell Biol       Date:  2004-10       Impact factor: 8.382

10.  Drosophila Apc1 and Apc2 regulate Wingless transduction throughout development.

Authors:  Yashi Ahmed; Ali Nouri; Eric Wieschaus
Journal:  Development       Date:  2002-04       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.